BlackRock Fund Advisors’s Asensus Surgical, Inc. ASXC Stock Holding History

BlackRock Fund Advisors’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$2.92M	Buy	172,660 +22,513	+15%	+$461K	﹤0.01%	3089
2016 Q3	$3.3M	Buy	150,147 +10,186	+7%	+$186K	﹤0.01%	3035
2016 Q2	$2.22M	Buy	139,961 +48,156	+52%	+$1.51M	﹤0.01%	3165
2016 Q1	$5.07M	Buy	91,805 +3,001	+3%	+$129K	﹤0.01%	2744
2015 Q4	$2.86M	Buy	88,804 +4,187	+5%	+$135K	﹤0.01%	3054
2015 Q3	$2.49M	Buy	84,617 +21,503	+34%	+$797K	﹤0.01%	3072
2015 Q2	$2.46M	Buy	63,114 +3,430	+6%	+$158K	﹤0.01%	3133
2015 Q1	$2.27M	Sell	59,684 -299	-0.5%	-$11.3K	﹤0.01%	3104
2014 Q4	$2.27M	Buy	59,983 +8,113	+16%	+$335K	﹤0.01%	3145
2014 Q3	$2.94M	Sell	51,870 -2,866	-5%	-$154K	﹤0.01%	3034
2014 Q2	$3.59M	Buy	+54,736	New	+$3.16M	﹤0.01%	3009

Other funds holding ASXC

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

IBT

International Biotechnology Trust London, United Kingdom $297M AUM 17.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock Fund Advisors's ASXC Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Asensus Surgical, Inc. (ASXC) stake by 15% in Q4 2016, buying an estimated $461K and bringing the position to 172,660 shares worth $2.92M. The position accounts for ﹤0.01% of the portfolio, ranked #3089.

BlackRock Fund Advisors first reported a position in ASXC in Q2 2014 and has held it in 11 quarters since. The position peaked at $5.07M in Q1 2016. 87 funds tracked by Wall St. Rank hold ASXC as of Q4 2016.

BlackRock Fund Advisors held 172,660 shares of Asensus Surgical, Inc. worth $2.92M as of Q4 2016.
BlackRock Fund Advisors bought 22,513 Asensus Surgical, Inc. shares in Q4 2016, an estimated $461K.
Asensus Surgical, Inc. made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3089 holding.
BlackRock Fund Advisors first reported a position in Asensus Surgical, Inc. in Q2 2014 and has held it in 11 quarters since.
BlackRock Fund Advisors's Asensus Surgical, Inc. position peaked at $5.07M in Q1 2016.
87 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.